Statistics
Publications
4
Citations
274
H-Index
4
Active since
2006
Affiliations
Houston Methodist(Current)
Muhammad Khan is an author at Houston Methodist specializing in toxicity management, metastatic disease treatment, and oncology.
Publications per year
2006–2008
4
4
A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC)
R. J. Amato, A. Misellati, Muhammad Khan et al. · Journal of Clinical Oncology · 2006 · 106 citations
Medicine, Oncology, Pharmacology +17
A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC)
J. Jac, S. Giessinger, Muhammad Khan et al. · Journal of Clinical Oncology · 2007 · 54 citations
Medicine, Oncology, Pharmacology +17
Lenalidomide Therapy for Metastatic Renal Cell Carcinoma
Robert J. Amato, Joan Hernandez-McClain, Somyata Saxena et al. · American Journal of Clinical Oncology · 2008 · 29 citations
Medicine, Oncology, Pharmacology +16
1–4 of 4